Tagged: Healthcare

Hc1.com disclosed issuing $6.02 million worth of equity


XDATA – October 1st 2015
Hc1.com reported closing its $6.02 million private placement yesterday. All the unregistered equity securities issued were acquired by one investor. A total of six unregistered securities offerings closed by the company raised an estimated $32.5 million.
Hc1.com markets a cloud-based customer relationship management platform built to address the critical need for healthcare systems, diagnostic laboratories, ambulatory service providers, and post acute care organizations to deliver an outstanding client experience. Investors include Elevate Ventures.
The company is headquartered in Indianapolis IN. Hc1.com elected to keep its revenues undisclosed.
The executive team includes Bradley Bostic and Chris Brown.
The board of directors includes John Baker, John Mills, Mark Shary and Tim Kopp.

The company has raised an estimated total of $38.52 million via private unregistered security offerings.

Offering recap
Status: Completed
Company: Hc1.com
Industry: Other Technology
Amount offered: $6.02 million
Amount placed: $6.02 million
SEC filing: Source
First sale: 09-30-2015
Data as of: 10-01-2015

 

Hey if you didn’t know about it, maybe it is time to add XDATA as part of your market monitoring regimen, 14 days free trials are available here.

For more information visit www.XDATA.co

$30 million equity placement completed by HealthEdge Software


XDATA – September 22nd 2014

healthedge HealthEdge Software disclosed raising $30 million as part of a brokered equity private placement. One investor acquired the securities on September 8th. The private placement’s expected net proceeds amounts to $28.2 million which excludes $1.8 million paid in brokerage fees. A total of fourteen unregistered securities offerings closed by the company raised an estimated $39.54 million.

The company is a provider of a cloud-based or on-site integrated financial, administrative and clinical platform for healthcare payors. It allows payors to leverage new business models including accountable care organizations (ACOs), health insurance exchanges (HIX), value-based benefits (VBBs) and pay-for-performance (P4P). It improves outcomes and the quality of care through transparent coordination among utilization management, case management, disease management and health and wellness functionality while drastically reducing administrative costs and manual processes.

The company is headquartered in Burlington MA. HealthEdge Software elected to keep its revenues undisclosed.
The executive team includes Matthew Hughes and Robert Gillette.
The board of directors includes Albert Waxman, Joseph Riley and Steve Krupa.

The company has raised an estimated total of $69.54 million via private unregistered security offerings.

Offering recap
Status: Completed
Company: HealthEdge Software
Industry: Other Technology
Amount offered: $30 million
Amount placed: $30 million
First sale: 09-08-2014
Data as of: 09-19-2014

For more information visit www.XDATA.co

Array Health re-opened and upped its offering cap to receive $11.38 million in commitments


Change: offered +49% / raised +26% / placed 85%

XDATA – September 19th 2014

array health Array Health re-opened and upped its equity financing to $13.38 million from $9 million after selling additional securities. One new investor bought $2.38 million worth of securities since the company last released data one month ago. This brings to $11.38 million the amount raised from the thirteen backers who subscribed to the offering. The private placement’s expected net proceeds will amount to $13.05 million, excluding $330,000 paid in brokerage fees by the company. The subscription is structured to close once the 15% left is fully subscribed or in about a year at the latest. The company closed five unregistered private placements which raised an estimated $4.08 million.

Array Health develops and markets a cloud-based and white-label application for health insurance companies to offer private insurance exchange.

The company, headquartered in Seattle WA, is led by Jonathan Rickert (President and CEO). Array Health elected to keep its revenues undisclosed.
The executive team includes Daniel Wolf.
The board of directors includes Brian Barefoot, Steven Nelson and William Pocklington.

The company has raised an estimated total of $15.45 million via private unregistered security offerings.

Array Health is registered under the name Array Health Solutions

Offering recap
Status: Intermediary close
Company: Array Health
Industry: Other Health Care
Amount offered: $13.38 million
Amount placed: $11.38 million
First sale: 08-05-2014
Data as of: 09-18-2014

For more information visit www.XDATA.co

Teladoc reported the completion of a $50.25 million financing round


XDATA – September 19th 2014

teladoc$50.25 million was raised by Teladoc following the successful placement and issuance of its unregistered equity securities. A total of forty investors participated to the non-brokered placement which started a little over a week ago. The company closed eight previous unregistered private placements which raised an estimated $40.6 million. The company is registered with the SEC under two distinct identification numbers.

Teladoc markets telehealth services. Through the company’s services patients consult with a physician via phone or secure online video to receive treatment for non-emergency medical issues, such as allergies, bronchitis, pink eye and sinus problems. The company is backed by Cardinal Partners, HLM Venture Partners, Kleiner Perkins Caufield & Byers, New Capital Partners, and Trident Capital.

The company is headquartered in Dallas TX. Revenues on or below $100 million were reported by Teladoc.
The executive team includes Daniel Trencher, Henry Dephillips, Jason Gorevic, Jeff Nadler, Kevin Williamson, Mark Hirschhorn, Mike King and Thomas Seaman.
The board of directors includes Arneek Multani, Dana G Mead, David B Snow, James Outland, Martin Felsenthal, Samuel Havens and Thomas Mckinley.

The company has raised an estimated total of $90.85 million via private unregistered security offerings.

Offering recap
Status: Completed
Company: Teladoc
Industry: Other Health Care
Amount offered: $50.25 million
Amount placed: $50.25 million
First sale: 09-09-2014
Data as of: 09-18-2014

For more information visit www.XDATA.co

First close initiated by PlushCare after raising 3% of its $1.5 million target


plushcareOne investor bought $50,000 worth of mezzanine securities from PlushCare three weeks ago. According to the data disclosed, the company expects to raise a total of $1.5 million via this non-brokered financing. An additional $1.45 million in funding is to be raised until the offering draws to a close in May 2015. Unregistered securities don’t appear to have been previously sold by the company.

PlushCare markets a HIPAA compliant platform offering virtual doctor visits. Users can book a virtual visit online for $40 for the diagnosis and treatment of common ailments such as influenza, upper respiratory infection, strep throat, and sinus infection among others. The service is available in California for now.

Ryan Mcquaid (CEO) leads the San Francisco CA based company which was registered in 2013. PlushCare kept its revenues undisclosed.

Offering recap
Status: First close
Company: PlushCare
Industry: Hospitals and Physicians
Amount offered: $1.5 million
Amount placed: $50,000
First sale: 05-22-2014
Data as of: 06-10-2014

Applied Bioresearch is in the market with a $750,000 investment round


Applied Bioresearch launched a $750,000 non-brokered equity offering based on information filed with the SEC. The subscription to the equity offering hasn’t started yet. The offering is structured to remain open until May 2015 or when the fundraising cap is reached, whichever one comes first. Two previous unregistered financing rounds raised an estimated $750,000.

The company is a research and development company in stealth mode. The company is combining several technologies to explore new solutions to the most pressing problems in biotechnology and healthcare.

The company, led by Kendal Svedeen, is headquartered in Draper UT. No revenues were reported by the company.

Offering recap
Status: Launched
Company: Applied Bioresearch
Industry: Pharmaceuticals
Amount offered: $750,000
Data as of: 05-30-2014

Mindoula Health reports successful placement of its mezzanine securities


mindoulaA $175,000 unregistered mezzanine investment round initiated by Mindoula Health was subscribed by four financial backers. According to the information disclosed, the placement started a week ago and was fully subscribed. No offering was previously initiated by the company under a registration exemption with the SEC.

Mindoula Health develops and markets remote or in-person behavioral health care management services. The company targets hospital and treatment centers, primary care physician practices, as well as patients and their families.

The company was registered in 2013 and has its headquarters located in Bethesda MD. Mindoula Health disclosed having revenues on or below $1 million.
The executive team includes Steven Sidel.

Offering recap
Status: Completed
Company: Mindoula Health
Industry: Other Technology
Amount offered: $175,000
Amount placed: $175,000
First sale: 05-16-2014
Data as of: 05-23-2014

$1.06 million unregistered debt financing and first close reported by ABT Molecular Imaging


ABT Molecular ImagingABT Molecular Imaging disclosed being in the market to raise $1.06 million via debt issuance. Apparently 73% or $775,000 has already been subscribed by three investors. The non-brokered placement started a few days ago. Based on the offering’s structure, the company has until May 2015 to raise an extra $288,000. A total of eight unregistered securities offerings closed by the company raised an estimated $22.05 million.

The company designed a device to manufacture doses of molecular imaging drugs for positron emission tomography (PET scanning) at the point of use. PET scanners map the body by means of injectable radioactive drugs that allow PET machines to highlight areas of abnormal metabolic function indicative of disease (such as cancer, Alzheimer’s disease, cardiac abnormalities, etc.).  ABT’s Biomarker Generator enables rapid, safe and local production of PET imaging agents in a way that is more convenient, versatile and significantly less expensive than current methods available. It is currently deployed to several research and clinical sites with installations in the U.S., Europe and South America.

The company is headquartered in Louisville TN. Abt Molecular Imaging disclosed having revenues on or below $1 million.

The executive team includes Michael Templin and Peter Kingma.
The board of directors includes Dennis Dougherty and Rik Vandevenne.

The company has raised an estimated total of $22.82 million via private unregistered security offerings.

Offering recap
Status: First close
Company: ABT Molecular Imaging
Industry: Biotechnology
Amount offered: $1.06 million
Amount placed: $775,000
First sale: 05-09-2014
Data as of: 05-12-2014

Protenus files details on its $50,000 financing


protenusProtenus raised $50,000 from three financial backers last Saturday according to information disclosed by the company. The non-brokered equity offering was fully subscribed. The equity offering’s estimated net proceeds amount to $38,000 excluding $12,000 earmarked for the payment of officers’ salaries. No offering was previously initiated by the company under a registration exemption with the SEC. The company is backed by accelerator dreamIt ventures.

The company markets an application (app) for hospitals which detects inappropriate electronic health records (EMR) access in real-time, with a focus on insider threats. By addressing unauthorized access at the moment of breach, the company’s solution will impact employee’s behavior to better protect patient privacy and minimize the risk of lawsuits, fines, and protect the establishment’s reputation.

The company, headquartered in Nottingham MD, was registered this year. The company reported having no revenues.

The board of directors includes Nicholas Culbertson and Robert Lord.

Offering recap
Status: Completed
Company: Protenus
Industry: Other Technology
Amount offered: $50,000
Amount placed: $50,000
First sale: 04-26-2014
Data as of: 05-02-2014

VoCare launched $20* million fundraising effort


vocareDespite filing an amendment for its Series A financing round, VoCare confirmed that the company is in the market to raise $20 million via a brokered equity private placement. The company structured the offering to remain open until April 2015 if not fully subscribed. No securities have been subscribed by investors yet. The private placement, excluding $500,000 to be paid toward officers’ salaries and $500,000 to be paid in placement fees, will bring in estimated net proceeds of $19 million. Until this disclosure VoCare had raised an estimated $5 million in unregistered securities via one previous financing round. The company disclosed to Random Research having raised $5 million as part of its Series A financing round despite its previous filing disclosing $3.35 million raised. The company is backed by SAW Capital and Elevate Ventures.

VoCare is a health tech company developing simple to use alert and monitoring products for seniors. Products include MyHealth Tablet which allows physicians and care giver to monitor patients remotely. The tablet has the ability to capture all patient vital signs (such as weight, blood pressure, glucose reading, temperature, oxygen level, and others), as well as conduct a “remote office visit” with a patient. It also offers audio and visual medication reminders, physical therapy alerts, and patient education on relevant topics. The tablet is Health Insurance Portability and Accountability Act (HIPAA) compliant. Other products include a personal emergency response system, a mobile phone solution as well as a call center.

The company, headquartered in Indianapolis IN, is led by Steven R Peabody (President and CEO). VoCare elected to keep its revenues undisclosed.

*The size is well outside our coverage however it shows how analysis and research can turn a questionable filing into news.

Offering recap
Status: Launched
Company: VoCare
Industry: Other Health Care
Amount offered: $20 million
Data as of: 04-25-2014